Skip to content

Author

J. Giorgi

We have 13 of 79 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Vericiguat and cardiovascular outcomes in heart failure revisited: a bayesian reanalysis of 12,877 patients

Heart failure (HF) remains a major global health burden. Vericiguat, a soluble guanylate cyclase stimulator, has been evaluated across HF phenotypes. However, trial results have been heterogeneous, leaving uncertainty regarding its clinical benefit. A Bayesian analysis would enable probabilistic estimation of tre...

P. Batista, R. R. A. Santos Silva, M. Montenegro et al. · 0 citations
Open access Oct 2026

Artificial intelligence–based assessment of breast arterial calcification on screening mammography and cardiovascular outcomes: a meta-analysis

Cardiovascular disease remains the leading cause of mortality in women, yet existing risk stratification tools frequently underestimate cardiovascular risk, particularly in younger and ostensibly low-risk populations. Breast arterial calcification (BAC), an incidental finding on routine screening mammography, has...

M. Malik, P. Batista, L. Lucena et al. · 0 citations
Review Open access Oct 2026

Left atrial–left ventricular coupling index as a novel diagnostic and prognostic marker in HFpEF: systematic review and meta-analysis

Diagnosing heart failure with preserved ejection fraction (HFpEF) remains challenging due to a broad spectrum of differential diagnoses. The left atrial coupling index (LACI) integrates the volume of the left atrium and the left ventricle at end-diastole and could be an echocardiographic marker to aid in a more a...

C. Bacca, J. Peres de Oliveira, R. Huntermann et al. · 0 citations
Review Open access Oct 2026

Sacubitril/valsartan and prevention of chemotherapy-induced cardiac dysfunction: meta-analysis of randomized trials

Chemotherapy-related cardiac dysfunction (CTRCD) is a major limitation of cardiotoxic cancer therapies. Although global longitudinal strain (GLS) allows early detection of myocardial injury, preventive strategies remain scarce. Angiotensin receptor–neprilysin inhibitors (ARNIs) may offer cardioprotection, but cur...

R. Huntermann, M. Molinari, P. Batista et al. · 0 citations
Open access Oct 2026

AI-enabled electrocardiography as a screening tool for peripartum cardiomyopathy: a meta-analysis of diagnostic accuracy

Peripartum cardiomyopathy (PPCM) remains an important cause of maternal morbidity and mortality, in part due to delayed recognition and limited feasibility of routine echocardiographic screening. Artificial intelligence (AI)–enabled electrocardiography (ECG) and digital auscultation tools have emerged as scalable...

R. Santos Silva, P. Batista, M. Montenegro et al. · 0 citations
Review Open access Oct 2026

Diagnostic accuracy of ai-enabled wearables for detecting atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis

Artificial intelligence (AI)–enabled monitoring has emerged as a promising approach for detecting atrial fibrillation (AF) recurrence after catheter ablation, providing continuous or high-frequency rhythm assessment beyond traditional ECG- and Holter-based follow-up. However, the diagnostic performance of AI-driv...

J. Giorgi, R. Huntermann, P. Batista et al. · 0 citations
Review Open access Oct 2026

Adverse pregnancy outcomes as early indicators of long-term maternal atrial fibrillation: a systematic review and meta-analysis

Adverse pregnancy outcomes (APOs) - including hypertensive disorders of pregnancy (HDP), preeclampsia, gestational diabetes mellitus (GDM), preterm birth, and fetal growth deviations - are emerging female-specific cardiovascular risk factors, but their association with long-term maternal atrial fibrillation (AF)...

P. Batista, R. Huntermann, M. Montenegro et al. · 0 citations
Review Oct 2026

Adverse pregnancy outcomes as early indicators of long-term maternal atrial fibrillation: a systematic review and meta-analysis.

BACKGROUND Adverse pregnancy outcomes (APOs) - including hypertensive disorders of pregnancy, preeclampsia, gestational diabetes mellitus (GDM), preterm birth, and fetal growth deviations - are emerging female-specific cardiovascular risk factors, but their association with long-term maternal atrial fibrillation (AF) r...

P. Batista, R. Huntermann, M. Montenegro et al. · 0 citations
Review Oct 2026

Impact of High-Dose Influenza Vaccine on Cardiorespiratory Outcomes in Older Adults: An Updated Systematic Review and Meta-Analysis.

INTRODUCTION Older adults face an increased risk of influenza-related complications, particularly cardiovascular (CV) events. The comparative effectiveness of high-dose inactivated influenza vaccine (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) for these outcomes remains uncertain. METHODS Data...

Larissa Araújo de Lucena, B. Hakkeem, N. Schettino Samad et al. · 0 citations
Review Aug 2026

Artificial intelligence analysis of the electrocardiogram for early identification of cancer therapy related cardiotoxicity: a systematic review and meta-analysis

Artificial intelligence-enabled ECG analysis demonstrates encouraging overall diagnostic accuracy for early identification of CTRCD, with high specificity and NPV, and larger studies are needed to clarify the role of AI-ECG as a complementary tool within cardio-oncology surveillance strategies.

M. Molinari, P. Batista, R. Huntermann et al. · 0 citations
Review Jul 2026

Clinical Consequences of Withdrawing Guideline-Directed Medical Therapy in Heart Failure with Improved Ejection Fraction: A Systematic Review and Meta-Analysis.

A paradigm of continued, lifelong GDMT is mandated for vast majority of HFimpEF patients as they remain vulnerable despite apparent recovery, and continuation of GDMT is essential to prevent relapse and improve survival.

T. Rehman, M. Faizan, Muhammad Waqas et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.